Amplitude Healthcare’s Business Combination with Jasper Therapeutics

Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics.

Amplitude Healthcare Corporation (Nasdaq: AMHC), a special purpose acquisition company sponsored by affiliates of Avego Management, LLC and Metalmark Capital, announced that it had entered into a business combination agreement with Jasper Therapeutics, Inc., a biotechnology company focused on hematopoietic cell transplant therapies.  Concurrently with execution of the business combination agreement, Amplitude entered into subscription agreements with investors for a $100 million committed PIPE financing, led by investors Federated Hermes Kaufmann Funds, Amgen, Apeiron Investment Group, Avego, Velan Capital, Metalmark, Kingdon Capital Management, Woodline Partners LP, Abingworth LLP, Qiming Venture Partners USA, Surveyor Capital (a Citadel company), Roche Venture Fund and Alexandria Venture Investments, LLC.

Upon closing of the transaction, the combined company is expected to be listed on Nasdaq under the new ticker symbol “JSPR,” and the company is expected to have an initial market capitalization of approximately $490 million. The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2021.

WilmerHale is representing Amplitude in the deal, with a team led by partners Chris Barnstable-Brown (Picture) and Glenn Pollner, which also included counsel Chip McCorkle, senior associate Victoria Peluso and associate J.P. Mohler on corporate matters, and partners Ciara Baker, Scott Kilgore, Julie Hogan Rodgers, Ariel Soiffer, Bruce Manheim, Hartmut Schneider, and Jason Chipman, senior attorney Edward Sharon, senior associate Ben Kelsey, and associates Lauren Roberts and Chris Shin on equity compensation, tax, employee benefits, intellectual property, antitrust and regulatory matters.

The Paul Hastings team included Jeff Hartlin and Jason Rabbitt-Tomita (Mergers and Acquisitions), Samantha Eldredge (Securities and Capital Markets), Scott Flicker (Regulatory), Dan Stellenberg (Employment), Todd Schneider (Corporate/IP), Mike Haun (Tax), of counsels Jeffrey Ii and Amy Lawrence, and associates, Laura Yip, Quinn Dang, Tiffany Jones, Matt Savoff, Derek Rogers and Mia Zhang.

Involved fees earner: Quinn Dang – Paul Hastings LLP; Samantha Eldredge – Paul Hastings LLP; Scott Flicker – Paul Hastings LLP; Jeff Hartlin – Paul Hastings LLP; Michael Haun – Paul Hastings LLP; Tiffany Jones – Paul Hastings LLP; Amy Lawrence – Paul Hastings LLP; Jason Rabbitt-Tomita – Paul Hastings LLP; Todd Schneider – Paul Hastings LLP; Dan Stellenberg – Paul Hastings LLP; Laura Yip – Paul Hastings LLP; Ciara Baker – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Christopher Barnstable-Brown – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Jason Chipman – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Julie Hogan Rodgers – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Benjamin Kelsey – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Scott Kilgore – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Bruce Manheim Jr – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Chip McCorkle – WilmerHaleWilmer Cutler Pickering Hale and Dorr; J.P. Mohler – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Victoria Peluso – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Glenn Pollner – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Lauren Roberts – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Hartmut Schneider – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Edward Sharon – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Christopher Shin – WilmerHaleWilmer Cutler Pickering Hale and Dorr; Ariel Soiffer – WilmerHaleWilmer Cutler Pickering Hale and Dorr;

Law Firms: Paul Hastings LLP; WilmerHaleWilmer Cutler Pickering Hale and Dorr;

Clients: Amplitude Healthcare Corp; Jasper Therapeutics;

Author: Martina Bellini